相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice
Yinfei Tan et al.
CANCER BIOLOGY & THERAPY (2015)
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10002
David A. Rizzieri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
B. Tolani et al.
ONCOGENE (2014)
A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis
Charles Torgbor et al.
PLOS PATHOGENS (2014)
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma
A. M. Evens et al.
ANNALS OF ONCOLOGY (2013)
Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status Final Results of a Phase 2 Study (Burkimab)
Josep-Maria Ribera et al.
CANCER (2013)
Low-Intensity Therapy in Adults with Burkitt's Lymphoma
Kieron Dunleavy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma
Gaetano Corazzelli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Epidemiology: clues to the pathogenesis of Burkitt lymphoma
Ian Magrath
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Roland Schmitz et al.
NATURE (2012)
The genetic landscape of mutations in Burkitt lymphoma
Cassandra Love et al.
NATURE GENETICS (2012)
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing
Julia Richter et al.
NATURE GENETICS (2012)
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis
J. A. Barnes et al.
ANNALS OF ONCOLOGY (2011)
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Jennifer A. Mertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens
Jennifer L. Kelly et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)
Graham M. Mead et al.
BLOOD (2008)
AIDS-associated Burkitt or Burkitt-like lymphoma:: Short intensive polychemotherapy is feasible and effective
Christian Hoffmann et al.
LEUKEMIA & LYMPHOMA (2006)
Molecular diagnosis of Burkitt's lymphoma
Sandeep S. Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Michael Hummel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma
KW Song et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
DA Thomas et al.
CANCER (2006)
Lymphorna incidence patterns by WHO subtype in the United States, 1992-2001
LM Morton et al.
BLOOD (2006)
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma - Final results of cancer and leukemia group B study 9251
DA Rizzieri et al.
CANCER (2004)
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study
GM Mead et al.
ANNALS OF ONCOLOGY (2002)
The distinction between Burkitt lymphoma and diffuse large B-cell lymphoma with c-Myc rearrangement
N Nakamura et al.
MODERN PATHOLOGY (2002)